- Veracyte (NASDAQ:VCYT -0.4%) acquires Massachusetts-based Allegro Diagnostics Corp. for $21.0M ($7.8M in cash and $13.2M in VCYT common stock).
- Allegro is developing a gene expression diagnostic test to improve the preoperative diagnosis of lung cancer. Veracyte intends to launch the test in 2H 2015, but meaningful revenue won't come in until 2017.
Veracyte buys diagnostics firm
Recommended For You
More Trending News
About VCYT Stock
Related Stocks
Symbol | Last Price | % Chg |
---|---|---|
VCYT | - | - |
Veracyte, Inc. |